We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$11.9B
AUM Growth
+$1.64B
Cap. Flow
+$3.17B
Cap. Flow %
26.56%
Top 10 Hldgs %
6.6%
Holding
3,409
New
939
Increased
912
Reduced
776
Closed
491

Sector Composition

Rank Sector Weight
1 Financials 22.64%
2 Technology 16.18%
3 Consumer Discretionary 11.16%
4 Industrials 10.33%
5 Healthcare 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYPH
2651
Cypherpunk Technologies Inc
CYPH
$73.3M
$46K ﹤0.01%
5,210
+10
+0.2% +$121
TALK icon
2652
Talkspace
TALK
$874M
$46K ﹤0.01%
45,200
-3,600
-7% -$5.28K
CARV
2653
DELISTED
Carver Bancorp
CARV
$45K ﹤0.01%
11,400
+100
+0.9% +$540
EVC icon
2654
Entravision Communication
EVC
$1.1B
$45K ﹤0.01%
11,400
-14,600
-56% -$72.3K
CDZI icon
2655
Cadiz
CDZI
$291M
$44K ﹤0.01%
22,800
+3,600
+19% +$12.1K
PROF
2656
Profound Medical
PROF
$269M
$44K ﹤0.01%
11,100
-100
-0.9% -$675
HOOD icon
2657
CALL
Robinhood
HOOD
$83.9B
$43K ﹤0.01%
50,000
-165,000
-77% -$1.59M
OXSQ icon
2658
Oxford Square Capital
OXSQ
$157M
$43K ﹤0.01%
14,400
+200
+1% +$736
QMCO icon
2659
Quantum Corp
QMCO
$474M
$41K ﹤0.01%
1,905
-75
-4% -$2.41K
NVVE
2660
DELISTED
Nuvve Holding Corp
NVVE
0
OLMA icon
2661
Olema Pharmaceuticals
OLMA
$1.05B
$40K ﹤0.01%
14,700
-17,200
-54% -$72.9K
OTLY
2662
Oatly Group
OTLY
$438M
$40K ﹤0.01%
765
-35
-4% -$2.42K
RPID icon
2663
Rapid Micro Biosystems
RPID
$86.2M
$40K ﹤0.01%
12,500
+2,500
+25% +$9.7K
EVLO
2664
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$40K ﹤0.01%
955
-10
-1% -$457
VRCA icon
2665
Verrica Pharmaceuticals
VRCA
$87.3M
$39K ﹤0.01%
1,340
-1,920
-59% -$65.8K
ICD
2666
DELISTED
Independence Contract Drilling, Inc.
ICD
$39K ﹤0.01%
12,900
BHC icon
2667
CALL
Bausch Health
BHC
$2.34B
$38K ﹤0.01%
+150,000
New +$1.04M
HOOK
2668
DELISTED
HOOKIPA Pharma
HOOK
$38K ﹤0.01%
2,850
ORIC icon
2669
Oric Pharmaceuticals
ORIC
$1.4B
$38K ﹤0.01%
11,800
-18,000
-60% -$72.1K
ITI
2670
DELISTED
Iteris, Inc.
ITI
$38K ﹤0.01%
12,900
-300
-2% -$897
ANGI icon
2671
Angi Inc
ANGI
$196M
$37K ﹤0.01%
+1,280
New +$56.4K
DAKT icon
2672
Daktronics
DAKT
$1.04B
$37K ﹤0.01%
13,400
-1,800
-12% -$6.19K
FDX icon
2673
PUT
FedEx
FDX
$75.4B
$36K ﹤0.01%
+20,000
New +$4.22M
GEVO icon
2674
Gevo
GEVO
$382M
$36K ﹤0.01%
+15,800
New +$44.1K
OXBR icon
2675
Oxbridge Re Holdings
OXBR
$10.8M
$36K ﹤0.01%
16,900
-100
-0.6% -$291

Similar funds

Schonfeld Strategic Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Schonfeld Strategic Advisors held 3,409 positions worth $11.9B, up 16% from $10.3B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.

Schonfeld Strategic Advisors deployed $3.17B of net new capital in Q3 2022, opening 939 new positions and adding to 912 existing holdings. Its largest new stake was Corebridge Financial: 3,204,461 shares worth $63.1M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gen Digital, an estimated $94.3M trimmed.

  • Schonfeld Strategic Advisors's largest Q3 2022 buy was Corebridge Financial: 3,204,461 shares worth $63.1M.
  • Schonfeld Strategic Advisors added most to Fidelity National Information Services in Q3 2022, an estimated $94M increase.
  • Schonfeld Strategic Advisors's biggest Q3 2022 reduction was Gen Digital, cutting an estimated $94.3M.
  • Schonfeld Strategic Advisors fully exited UMB Financial in Q3 2022, selling an estimated $33.6M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 6.6% of its $11.9B portfolio in Q3 2022.
  • Schonfeld Strategic Advisors opened 939 new positions and closed 491 in Q3 2022.
  • Schonfeld Strategic Advisors's portfolio value rose 16% quarter-over-quarter to $11.9B.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.